Sin Nombre viral RNA load in patients with hantavirus cardiopulmonary syndrome.
about
Hemorrhagic Fever with Renal Syndrome: Pathogenesis and Clinical PictureThe Syrian hamster model of hantavirus pulmonary syndromePathophysiology of hantavirus pulmonary syndrome in rhesus macaques.Hantaviruses in the americas and their role as emerging pathogensExperimental Andes virus infection in deer mice: characteristics of infection and clearance in a heterologous rodent hostIndirect immunofluorescence assay for the simultaneous detection of antibodies against clinically important old and new world hantaviruses.Treatment of hantavirus pulmonary syndromeViral load and humoral immune response in association with disease severity in Puumala hantavirus-infected patients--implications for treatmentElevated cytokines, thrombin and PAI-1 in severe HCPS patients due to Sin Nombre virus.Small interfering RNA inhibition of Andes virus replication.Temporal analysis of Andes virus and Sin Nombre virus infections of Syrian hamstersClinical characterization of two severe cases of hemorrhagic fever with renal syndrome (HFRS) caused by hantaviruses Puumala and Dobrava-Belgrade genotype SochiElevated VEGF Levels in Pulmonary Edema Fluid and PBMCs from Patients with Acute Hantavirus Pulmonary Syndrome.Molecular method for the detection of Andes hantavirus infection: validation for clinical diagnosticsHantaviruses direct endothelial cell permeability by sensitizing cells to the vascular permeability factor VEGF, while angiopoietin 1 and sphingosine 1-phosphate inhibit hantavirus-directed permeability.High-dose intravenous methylprednisolone for hantavirus cardiopulmonary syndrome in Chile: a double-blind, randomized controlled clinical trialPotential renal sequelae in survivors of hantavirus cardiopulmonary syndrome.Hantavirus infections in Europe: from virus carriers to a major public-health problem.T cells and pathogenesis of hantavirus cardiopulmonary syndrome and hemorrhagic fever with renal syndrome.Lambda interferon (IFN-lambda) in serum is decreased in hantavirus-infected patients, and in vitro-established infection is insensitive to treatment with all IFNs and inhibits IFN-gamma-induced nitric oxide production.Puumala hantavirus viremia diagnosed by real-time reverse transcriptase PCR using samples from patients with hemorrhagic fever and renal syndrome.Viral load of patients with hantavirus pulmonary syndrome in Argentina.Andes virus antigens are shed in urine of patients with acute hantavirus cardiopulmonary syndrome.Development of a one-step SYBR Green I real-time RT-PCR assay for the detection and quantitation of Araraquara and Rio Mamore hantavirusInfection of human monocyte-derived dendritic cells by ANDES Hantavirus enhances pro-inflammatory state, the secretion of active MMP-9 and indirectly enhances endothelial permeability.Upregulation of P2Y2R, Active uPA, and PAI-1 Are Essential Components of Hantavirus Cardiopulmonary Syndrome.Bunyavirus: Hemorrhagic FeversMaripa Virus RNA Load and Antibody Response in Hantavirus Pulmonary Syndrome, French Guiana
P2860
Q26766338-790315CA-DCAD-44A4-A483-8001AA914301Q27027405-6670CCCC-925C-4911-AC71-A9F852F762CFQ33414924-3361E2AE-6CDA-43E6-A6DB-A515C281978BQ34047494-375E11C8-D778-4335-9B23-05EA936EB29DQ34576370-E663636A-9CF3-4736-9F96-0B2E2663F8B3Q34675117-8B2A0D75-7FA2-441A-A62A-BD14DF05D355Q34727873-081760B7-D4BA-4821-80EF-BA45103B52E4Q34853904-65E8B73B-E022-48DF-BF97-F63D83393314Q35159993-318506AC-E3D4-45DE-8428-9041736C8123Q35187123-E9D427C5-91ED-4AC1-A910-484B416996B1Q35914518-6494D42F-B55E-4097-8663-0F1BFB0E2CF6Q36191969-2326A997-6301-4A74-AAF9-5C94A83191BCQ36203887-DED4DBE3-63D0-4059-91CD-E180C1817B7AQ36583530-5E4CB7B0-9CBD-48D8-BB33-BBB127A7E539Q36673210-79346961-27CA-4BD6-9269-A7C49D1A853FQ37151502-9A46E113-41B1-4AB6-8120-E4D178D6854AQ37252390-F81664A3-1FFB-42D0-B195-F606E8E98961Q37404844-E67BD181-8188-4EC8-A7F7-4A633D0972D3Q37945235-71E0BE55-9E92-46AF-BD36-659D3A575FD8Q40210250-3B8EC3D9-D41C-4E82-843D-AB241909DAFEQ40448660-F44DEACB-2D97-47E5-B2FA-78E3F81ABE5FQ41152443-291033EE-794C-4B18-9192-2E2FD3AB034FQ41839818-64524364-F85C-4B5C-9795-649B9486075EQ41853179-8AB4C33C-CF07-4EA0-928D-DDF39AA6154AQ42741533-D2573FA6-3DCE-45A6-91CB-B8D57050EC7EQ55261603-0492A559-CE0A-45EB-8D73-4A464FCFF5A4Q56537260-8AA029FD-5489-42AF-9770-EA64FF12EF15Q58777829-B769D56C-2365-4997-A646-084E62429EFF
P2860
Sin Nombre viral RNA load in patients with hantavirus cardiopulmonary syndrome.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Sin Nombre viral RNA load in patients with hantavirus cardiopulmonary syndrome.
@en
Sin Nombre viral RNA load in patients with hantavirus cardiopulmonary syndrome.
@nl
type
label
Sin Nombre viral RNA load in patients with hantavirus cardiopulmonary syndrome.
@en
Sin Nombre viral RNA load in patients with hantavirus cardiopulmonary syndrome.
@nl
prefLabel
Sin Nombre viral RNA load in patients with hantavirus cardiopulmonary syndrome.
@en
Sin Nombre viral RNA load in patients with hantavirus cardiopulmonary syndrome.
@nl
P2093
P356
P1476
Sin Nombre viral RNA load in patients with hantavirus cardiopulmonary syndrome.
@en
P2093
Chris Stidley
Chunyan Ye
Fred Koster
Ruobing Xiao
P304
P356
10.1086/508494
P407
P50
P577
2006-10-10T00:00:00Z